John L. Lamattina - 10 Jun 2026 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Reporting relationship: Director
Issuer ticker: LGND
Reported as of: 10 Jun 2026
Net transaction value: -$1,151,774
SEC form: 4
Accepted by SEC: 12 Jun 2026, 17:26:25 UTC
Prior SEC filing: 09 Jun 2026
Source filing: View source filing
Reporting owner signature: By: /s/ Andrew Reardon, Attorney-in-Fact For: John L. LaMattina

Key filing fact

John L. Lamattina filed Form 4 for LIGAND PHARMACEUTICALS INC (LGND) on 12 Jun 2026.

Key facts

This page summarizes John L. Lamattina's Form 4 filing for LIGAND PHARMACEUTICALS INC (LGND).
4 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 12 Jun 2026, 17:26.

Change

Previous filing in this sequence was filed on 09 Jun 2026.
Current net transaction value: -$1,151,774.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001216074 Primary reporting owner

LAMATTINA JOHN L

Relationship: Director
Address: 555 HERITAGE DRIVE, SUITE 200, JUPITER
Signature: By: /s/ Andrew Reardon, Attorney-in-Fact For: John L. LaMattina
Signature date: 12 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LGND transaction

Common Stock

Sale

Transaction value: $63,536
Shares: -257
Change %: -0.81%
Price: $247.22
Shares after: 31,303
Date: 10 Jun 2026
Ownership: Direct
Footnotes: F1

LGND transaction

Common Stock

Sale

Transaction value: $57,562
Shares: -232
Change %: -0.74%
Price: $248.11
Shares after: 31,071
Date: 10 Jun 2026
Ownership: Direct
Footnotes: F2

LGND transaction

Common Stock

Sale

Transaction value: $173,924
Shares: -697
Change %: -2.2%
Price: $249.53
Shares after: 30,374
Date: 10 Jun 2026
Ownership: Direct
Footnotes: F3

LGND transaction

Common Stock

Sale

Transaction value: $856,752
Shares: -3,405
Change %: -11%
Price: $251.62
Shares after: 26,969
Date: 10 Jun 2026
Ownership: Direct
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $246.6300 to $247.6100. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F2

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $247.9400 to $248.3350. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $249.3400 to $250.2700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F4

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $250.9100 to $251.8950. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.